Summary
This study investigated the modulation of type I collagen gene expression in normal fibroblasts by breast tumour cells. Northern analysis of total RNA extracted from stages I, II and III breast tumour tissue revealed that collagen mRNA levels were elevated in stage I tumours compared to the adjacent normal breast tissues, whereas they were decreased in stages II and III breast tumours. This aberrant collagen gene expression was confirmed by non-radioactive RNA:RNA in situ hybridization analysis of 30 breast carcinomas which localized the production of type I collagen mRNA to the stromal fibroblasts within the vicinity of the tumour cells. In order to determine whether the tumour cells were directly responsible for this altered collagen production by the adjacent fibroblasts, breast tumour cell lines were co-cultured with normal fibroblasts for in vitro assessment of collagen and steady-state collagen RNA levels. Co-culture of tumour cells and normal fibroblasts in the same dish resulted in down-regulation of collagen mRNA and protein. Treatment of the fibroblasts with tumour-cell conditioned medium also resulted in decreased collagen protein levels but the mRNA levels, however, remained unaltered. These results suggested that the tumour cells either secrete a labile ‘factor’, or express a cell surface protein requiring direct contact with the fibroblasts, resulting in down-regulation of collagen gene expression. Modulation of the ECM is a common characteristic of invading tumour cells and usually involves increased production of collagenases by the tumour cells or stromal fibroblasts. This study showed that tumour cells were also able to modulate collagen mRNA production by stromal fibroblasts, which may facilitate tumour cell invasion and metastasis.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Al-Adanani, MS, Kirrane, JA & McGee, JOD (1975). Inappropriate production of collagen and prolyl hydroxyproline by human breast carcinoma cells in vivo. Br J Cancer 31: 653–660.
Armendariz-Borunda, J, Katayama, K & Seyer, JM (1992). Transcriptional mechanisms of type I collagen gene expression are differentially regulated by interleukin 1β, tumor necrosis factor α1 and transforming growth factor β in Ito cells. J Biol Chem 267: 14316–14321.
Barsky, SH, Rao, CN, Grotendorst, GR & Liotta, LA (1982). Increased content of type V collagen in desmoplasia of human breast carcinoma. Am J Pathol 108: 276–283.
Barsky, SH & Gopalakrishna, R (1987). Increased invasion and spontaneous metastasis of BL6 melanoma with inhibition of the desmoplastic response. Cancer Res 47: 1663–1667.
Basset, P, Bellocq, JP, Wolf, C, Stoll, I, Hutin, P, Limacher, JM, Podhajcer, OL, Chenard, MP, Rio, MC & Chambon, P (1990). A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 348: 699–704.
Biswas, C (1982). Tumor cell stimulation of collagenase production by fibroblasts. Biochem Biophys Res Comm 109: 1026–1034.
Biswas, C (1984). Collagenase stimulation in co-culture of human fibroblasts and human tumour cells. Cancer Lett 24: 201–207.
Chomczynski, P & Sacchi, N (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156–159.
Chu, ML, Myers, JC, Bernard, MP, Ding, JF & Ramirez, F (1982). Cloning and characterization of five overlapping cDNAs specific for the human pro alpha 1(I) collagen chain. Nucleic Acids Res 10: 5925–5934.
Harris, JR, Lippman, ME, Veronisi, U & Willet, W (1992). Breast cancer. N Engl J Med 327: 473–480.
Hewitt, RE, Powe, DG, Carter, GI & Turner, DR (1993). Desmoplasia and its relevance to colorectal tumour invasion. Int J Cancer 53: 62–69.
Hoefakker, S, Boersma, WJA & Claassen, E (1995). Detection of human cytokines in situ using antibody and probe based methods. J Immunol Methods 185: 149–175.
Kauppila, S, Stenback, F, Risteli, J, Jukkola, A & Risteli, L (1998). Aberrant type I and type III collagen gene expression in human breast cancer in vivo. J Pathol 186: 262–268.
Liotta, LA, Rao, CN & Barsky, SH (1983). Tumour invasion and the extracellular matrix. Lab Invest 49: 636–649.
Myers, JC, Chu, ML, Faro, SH, Clark, WJ, Prockop, DJ & Ramirez, F (1981). Cloning a cDNA for the pro alpha 2 chain of human type I collagen. Proc Natl Acad Sci USA 78: 3516–3520.
Nakanishi, H, Oguri, K, Takenaga, K, Hosoda, S & Okayama, M (1994). Differential fibrotic stromal responses of host tissue to low- and high-metastatic cloned Lewis lung carcinoma cells. Lab Invest 70: 324–332.
Niitsu, Y, Ito, N, Kohda, K, Owada, M, Morita, K, Sato, S, Watanabe, N, Kohgo, Y & Urushizaki, I (1988). Immunohistochemical identification of type I procollagen in tumour cells of scirrhous adenocarcinoma of the stomach. Br J Cancer 57: 79–82.
Noel, A, Munaut, C, Boulvain, A, Calberg-Bacq, CM, Lambert, CA, Nusgeus, B, Lapiere, CM & Foidart, JM (1992). Modulation of collagen and fibronectin synthesis in fibroblasts in normal and malignant cells. J Cell Biochem 48: 150–161.
Ohtani, H, Kuroiwa, A, Obinata, M, Ooshima, A & Nagura, H (1992). Identification of type I collagen-producing cells in human gastrointestinal carcinomas by non-radioactive in situ hybridisation and immunoelectron microscopy. J Histochem Cytochem 40: 1139–1146.
Pauli, BU, Schwartz, DE, Thonar, EJ & Knettner, KE (1983). Tumor invasion and host extracellular matrix. Cancer Metastas Rev 2: 129–152.
Peterkofsky, B & Diegelmann, R (1974). Use of a mixture of proteinase-free collagenases for the specific assay of radioactive collagen in the presence of other proteins. Biochemistry 10: 988–993.
Pucci-Minafra, I, Minafra, S, Sciarrino, S, Tomasino, RM & Tinervia, RJ (1986). Collagen changes in the ductal infiltrating (schirrous) carcinoma of the human breast. A possible role played by type I trimer collagen on the invasive growth. Submicrosc Cytol 18: 795–805.
Roesel, RA, Cutroneo, KR, Scott, DF & Howard, EF (1978). Collagen synthesis by cloned mouse mammary tumour cells. Cancer Res 38: 3269–3275.
Sakakibara, K, Suzuki, T, Motoyama, T, Watanabe, H & Nagai, Y (1982). Biosynthesis of an interstitial type of collagen by cloned human gastric carcinoma cells. Cancer Res 42: 2019–2027.
Smith, DR, Kunkel, SL, Burdick, MD, Wilke, CA, Orringer, MB, Whyte, RI & Strieter, RM (1994). Production of interleukin-10 by human bronchogenic carcinoma. Am J Pathol 145: 18–25.
van der Hooff, A (1988). Stromal involvement in malignant growth. Adv Cancer Res 50: 159–196.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Fenhalls, G., Geyp, M., Dent, D. et al. Breast tumour cell-induced down-regulation of type I collagen mRNA in fibroblasts. Br J Cancer 81, 1142–1149 (1999). https://doi.org/10.1038/sj.bjc.6690821
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690821
Keywords
This article is cited by
-
Real-time polarization microscopy of fibrillar collagen in histopathology
Scientific Reports (2021)
-
Anti-matrix metalloproteinase-9 DNAzyme decreases tumor growth in the MMTV-PyMT mouse model of breast cancer
Breast Cancer Research (2013)
-
Tumour cells down-regulate CCN2 gene expression in co-cultured fibroblasts in a Smad7- and ERK-dependent manner
Cell Communication and Signaling (2013)
-
Down-regulation of type I collagen by breast tumour cells
Breast Cancer Research (1999)